Gynaecomastia associated with highly active antiretroviral therapy (HAART)
DOI:
https://doi.org/10.3941/jrcr.v4i7.452Keywords:
Gynaecomastia imaging, HIV, AIDS, highly active antiretroviral therapy, HAARTAbstract
There is a global Acquired Immune Deficiency Syndrome (AIDS) epidemic. It is estimated that the total number of people living with Human Immune deficiency Virus (HIV) is 33.2 million in the year 2007. An estimated 2.1 million people died from AIDS in 2007. As highly active antiretroviral therapy (HAART) becomes more widely used, the side effects of this regime are becoming more evident in clinical practice. We present 2 cases that demonstrate the association of HAART and gynaecomastia. Imaging features of gynaecomastia and the differential for these changes will be reviewed. Proposed mechanisms for the pathogenesis of gynaecomastia will be discussed. Possible therapeutic options will also be briefly considered.
Published
2010-06-27
Issue
Section
Breast Imaging
License
The publisher holds the copyright to the published articles and contents. However, the articles in this journal are open-access articles distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License, which permits reproduction and distribution, provided the original work is properly cited. The publisher and author have the right to use the text, images and other multimedia contents from the submitted work for further usage in affiliated programs. Commercial use and derivative works are not permitted, unless explicitly allowed by the publisher.
